China Resources Double-Crane Pharmaceutical Co.,Ltd.’s Net Profit Rose 25% in 2022

China Resources Double-Crane Pharmaceutical Co.,Ltd. (华润双鹤药业股份有限公司) (600062.SH) reported a net profit of 1.2 billion yuan in 2022, up 25% year-on-year.

Meanwhile, the company posted 9.4 billion yuan in revenue, up 3.7% year-on-year.

At the end of the reporting period, it had 14.5 billion yuan in total assets and 3.8 billion yuan in total liabilities, with a liability-to-asset ratio of 25.9%.